Shanghai Depeac Biotechnology

Shanghai Depeac Biotechnology is a biotechnology company based in Shanghai, China, specializing in regenerative medicine and advanced wound care. The company focuses on the development of tetrahedral framework nucleic acids (tFNA) and recombinant human collagen type III to promote scar-free wound healing. Their research demonstrates that tFNA induces keratinocyte autophagy through the AMPK/mTOR/ULK1 pathway, enhancing cell proliferation and migration while reducing scar formation. Depeac collaborates extensively with academic institutions like Fudan University and Naval Medical University to translate molecular engineering into clinical solutions for skin defects and chronic wounds.